Business Context and Reporting Period
This Form 8-K is a current report filed by Renovaro Inc. (not Lunai Bioworks Inc.) on November 4, 2024. The filing discloses the execution of an amended and restated consulting agreement with Tarsh PB Advisors regarding the services of Simon Tarsh as the Company's Interim Chief Financial Officer.
Key Financial Metrics
This filing does not contain standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial data disclosed relates to executive compensation:
- Monthly Fee: $25,000 per month for full-time Interim CFO services.
- Performance Bonus: Up to 30% of the consideration paid under the agreement upon achievement of certain milestones.
- One-time Bonuses: $29,063 paid on October 31, 2024, and an additional $29,063 scheduled for November 30, 2024.
- Equity Compensation: 58,500 stock options vesting upon termination if a new CFO is hired prior to that date.
Material Changes
The material change reported is the formalization of the Interim CFO's compensation structure effective November 4, 2024. The agreement establishes a three-month initial term with options for successive one-month renewals and allows for termination by either party with thirty days' advance written notice.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, market outlook, or discussion of general business risks. The primary contingency noted is the vesting condition for the 58,500 stock options, which is tied to the hiring of a permanent CFO prior to the termination of the interim agreement.
Investor Verification Checklist
- Verify the correct registrant name is Renovaro Inc. (Ticker: RENB), not Lunai Bioworks Inc.
- Confirm the total cash compensation obligation for the interim period ($25,000/month plus bonuses).
- Review the specific milestones required to trigger the additional 30% performance payment.
- Monitor the timeline for the appointment of a permanent CFO to determine the vesting status of the 58,500 stock options.